DROSPIRENONE AND ESTETROL

DROSPIRENONE AND ESTETROL was reported 296 times

DROSPIRENONE AND ESTETROL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC PERFUSION DISORDER 1 0.0476
1 DECIDUAL CAST 1 0.0200
2 MUCOEPIDERMOID CARCINOMA 1 0.0105
3 SWEAT GLAND INFECTION 1 0.0079
4 MANIC SYMPTOM 1 0.0060
5 VISUAL SNOW SYNDROME 1 0.0054
6 INTERMENSTRUAL BLEEDING 26 0.0046
7 ANDROGENETIC ALOPECIA 1 0.0035
8 OESTRADIOL INCREASED 1 0.0033
9 LACUNAR STROKE 1 0.0031
10 PRINZMETAL ANGINA 3 0.0030
11 PREGNANCY TEST POSITIVE 1 0.0025
12 MEDICAL INDUCTION OF COMA 1 0.0024
13 HEAVY MENSTRUAL BLEEDING 21 0.0023
14 SPLENIC VEIN THROMBOSIS 1 0.0020
15 ORTHOPAEDIC PROCEDURE 1 0.0019
16 PREGNANCY ON ORAL CONTRACEPTIVE 5 0.0019
17 ENDOMETRIAL THICKENING 1 0.0018
18 DERMATOSIS 1 0.0016
19 ALLERGIC OEDEMA 1 0.0015
20 INGROWN HAIR 1 0.0014
21 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
22 WITHDRAWAL BLEED 1 0.0014
23 CHLAMYDIAL INFECTION 1 0.0013
24 SUPERIOR SAGITTAL SINUS THROMBOSIS 1 0.0013
25 IIIRD NERVE PARALYSIS 1 0.0012
26 LIP PRURITUS 1 0.0012
27 CATHETER SITE PRURITUS 1 0.0011
28 UTERINE SPASM 2 0.0011
29 RETINAL EXUDATES 1 0.0011
30 VASCULAR PAIN 1 0.0010
31 MESENTERIC VEIN THROMBOSIS 1 0.0010
32 BREAST TENDERNESS 7 0.0009
33 BINGE EATING 1 0.0009
34 LIGAMENT INJURY 1 0.0009
35 CAROTID ARTERY DISEASE 1 0.0008
36 OVARIAN CYST RUPTURED 1 0.0008
37 MIGRAINE WITH AURA 2 0.0007
38 DISCHARGE 1 0.0007
39 PREGNANCY ON CONTRACEPTIVE 1 0.0007
40 POLYMENORRHOEA 2 0.0006
41 FIBRIN D DIMER INCREASED 2 0.0006
42 BREAST DISORDER 1 0.0005
43 IMPULSE-CONTROL DISORDER 1 0.0005
44 MENSTRUAL DISORDER 4 0.0005
45 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
46 SWELLING OF EYELID 3 0.0005
47 INFUSION SITE BRUISING 1 0.0005
48 MENSTRUATION DELAYED 5 0.0005
49 OLIGOMENORRHOEA 1 0.0005
50 DYSMENORRHOEA 6 0.0005
51 PULMONARY INFARCTION 1 0.0004
52 HEPATIC ENZYME ABNORMAL 2 0.0004
53 ABNORMAL UTERINE BLEEDING 1 0.0004
54 AFFECTIVE DISORDER 3 0.0004
55 MOOD SWINGS 12 0.0004
56 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
57 ABDOMINAL RIGIDITY 1 0.0004
58 HAEMATOLOGICAL MALIGNANCY 1 0.0004
59 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
60 NEGATIVE THOUGHTS 1 0.0003
61 MENSTRUATION IRREGULAR 9 0.0003
62 EMBOLISM VENOUS 1 0.0003
63 BLADDER PAIN 1 0.0003
64 PORTAL VEIN THROMBOSIS 1 0.0003
65 BREAST ENLARGEMENT 1 0.0003
66 BREAST MASS 2 0.0003
67 TACHYPHRENIA 1 0.0003
68 BREAST PAIN 3 0.0003
69 UTERINE LEIOMYOMA 2 0.0003
70 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
71 APHTHOUS ULCER 2 0.0003
72 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
73 PAPILLOEDEMA 1 0.0002
74 IMMUNE THROMBOCYTOPENIA 1 0.0002
75 VAGINAL INFECTION 1 0.0002
76 HUMERUS FRACTURE 1 0.0002
77 NASAL POLYPS 1 0.0002
78 PARTIAL SEIZURES 1 0.0002
79 INTRACRANIAL PRESSURE INCREASED 1 0.0002
80 PERIORBITAL SWELLING 1 0.0002
81 SKIN WARM 1 0.0002
82 PRODUCT LABEL CONFUSION 1 0.0002
83 VAGINAL HAEMORRHAGE 7 0.0002
84 TENDON DISORDER 1 0.0002
85 BLINDNESS TRANSIENT 1 0.0001
86 SUNBURN 1 0.0001
87 ANKLE FRACTURE 2 0.0001
88 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
89 ANGER 4 0.0001
90 SKIN HYPERPIGMENTATION 1 0.0001
91 HYSTERECTOMY 1 0.0001
92 SKIN SWELLING 1 0.0001
93 SUICIDAL IDEATION 10 0.0001
94 APPENDICITIS 1 0.0001
95 MIGRAINE 10 0.0001
96 COELIAC DISEASE 1 0.0001
97 VITREOUS FLOATERS 1 0.0001
98 INABILITY TO AFFORD MEDICATION 1 0.0001
99 OVARIAN CYST 1 0.0001
100 PREGNANCY 2 0.0001
101 VAGINAL DISCHARGE 1 0.0001
102 TEMPERATURE INTOLERANCE 1 0.0001
103 POOR VENOUS ACCESS 1 0.0001
104 FOLLICULITIS 1 0.0001
105 INJECTION SITE DISCOMFORT 1 0.0001
106 PULMONARY THROMBOSIS 1 0.0001
107 HEART RATE IRREGULAR 2 0.0001
108 MADAROSIS 1 0.0001
109 BLOOD IRON DECREASED 1 0.0001
110 PULMONARY EMBOLISM 8 0.0001
111 MUSCLE RIGIDITY 1 0.0001
112 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
113 EXPOSURE DURING PREGNANCY 5 0.0001
114 ACNE 6 0.0001
115 IMMUNE SYSTEM DISORDER 1 0.0001
116 MOOD ALTERED 2 0.0001
117 HUNGER 1 0.0001
118 APHONIA 1 0.0001
119 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
120 HYPOKINESIA 1 0.0001
121 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
122 ARRHYTHMIA 3 0.0001
123 ULCER 1 0.0001
124 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
125 LIP SWELLING 2 0.0001
126 HEMIPARESIS 1 0.0001
127 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
128 AMENORRHOEA 1 0.0001
129 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
130 DRUG ERUPTION 1 0.0001
131 CRYING 2 0.0001
132 PANIC ATTACK 2 0.0001
133 FRACTURE 1 0.0001
134 PRODUCT SUBSTITUTION ISSUE 3 0.0001
135 CHOKING 1 0.0001
136 DISABILITY 1 0.0001
137 COMPLICATION OF DEVICE INSERTION 1 0.0001
138 ABORTION SPONTANEOUS 2 0.0000
139 INTENTIONAL SELF-INJURY 1 0.0000
140 FEEDING DISORDER 1 0.0000
141 TASTE DISORDER 1 0.0000
142 BODY TEMPERATURE INCREASED 1 0.0000
143 ABDOMINAL DISTENSION 5 0.0000
144 MOUTH ULCERATION 1 0.0000
145 IMPAIRED WORK ABILITY 1 0.0000
146 IRRITABLE BOWEL SYNDROME 1 0.0000
147 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
148 WEIGHT INCREASED 10 0.0000
149 THERAPY NON-RESPONDER 2 0.0000
150 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
151 CHROMATURIA 1 0.0000
152 MUSCLE TWITCHING 1 0.0000
153 PALPITATIONS 5 0.0000
154 PRODUCT PRESCRIBING ERROR 1 0.0000
155 THERAPY INTERRUPTED 3 0.0000
156 RASH ERYTHEMATOUS 2 0.0000
157 NEURALGIA 1 0.0000
158 ALOPECIA 8 0.0000
159 DRY EYE 2 0.0000
160 DEPRESSION 9 0.0000
161 ABDOMINAL PAIN LOWER 1 0.0000
162 EAR INFECTION 1 0.0000
163 THROMBOSIS 3 0.0000
164 VISION BLURRED 5 0.0000
165 PROCEDURAL PAIN 1 0.0000
166 FEELING COLD 1 0.0000
167 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
168 PSYCHOTIC DISORDER 1 0.0000
169 IRRITABILITY 2 0.0000
170 APHASIA 1 0.0000
171 HYPERSENSITIVITY 6 0.0000
172 LIMB DISCOMFORT 1 0.0000
173 MOVEMENT DISORDER 1 0.0000
174 DEEP VEIN THROMBOSIS 2 0.0000
175 OSTEONECROSIS 1 0.0000
176 HEART RATE INCREASED 3 0.0000
177 FUNGAL INFECTION 1 0.0000
178 EYE PRURITUS 1 0.0000
179 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
180 HEPATIC ENZYME INCREASED 2 0.0000
181 CHEST DISCOMFORT 3 0.0000
182 ILLNESS 3 0.0000
183 HAEMORRHAGE 3 0.0000
184 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
185 DYSURIA 1 0.0000
186 EYE SWELLING 1 0.0000
187 MUSCULAR WEAKNESS 3 0.0000
188 DIZZINESS 13 0.0000
189 SEIZURE 3 0.0000
190 HEADACHE 16 0.0000
191 INFLUENZA LIKE ILLNESS 2 0.0000
192 ROAD TRAFFIC ACCIDENT 1 0.0000
193 INSOMNIA 6 0.0000
194 TACHYCARDIA 2 0.0000
195 COLITIS ULCERATIVE 1 0.0000
196 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
197 NEPHROLITHIASIS 1 0.0000
198 MUSCLE SPASMS 4 0.0000
199 ADVERSE EVENT 2 0.0000
200 BLOOD CHOLESTEROL INCREASED 1 0.0000
201 HYPOAESTHESIA 3 0.0000
202 FLUID RETENTION 1 0.0000
203 PERIPHERAL SWELLING 3 0.0000
204 INFLAMMATION 1 0.0000
205 DEPRESSED MOOD 1 0.0000
206 RASH PRURITIC 1 0.0000
207 OEDEMA 1 0.0000
208 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
209 URTICARIA 3 0.0000
210 EYE PAIN 1 0.0000
211 URINARY TRACT INFECTION 3 0.0000
212 ANXIETY 5 0.0000
213 LETHARGY 1 0.0000
214 PAIN IN EXTREMITY 5 0.0000
215 SUICIDE ATTEMPT 1 0.0000
216 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
217 CHEST PAIN 3 0.0000
218 VISUAL IMPAIRMENT 2 0.0000
219 INJECTION SITE ERYTHEMA 2 0.0000
220 MALAISE 7 0.0000
221 INTENTIONAL OVERDOSE 1 0.0000
222 BLOOD PRESSURE DECREASED 1 0.0000
223 HYPOTENSION 3 0.0000
224 INJECTION SITE PRURITUS 1 0.0000
225 INJECTION SITE REACTION 1 0.0000
226 BURNING SENSATION 1 0.0000
227 DYSPNOEA 8 0.0000
228 SKIN BURNING SENSATION 1 0.0000
229 NAUSEA 11 0.0000
230 RASH 6 0.0000
231 OFF LABEL USE 12 0.0000
232 AGITATION 1 0.0000
233 PRODUCT DOSE OMISSION ISSUE 4 0.0000
234 DYSGEUSIA 1 0.0000
235 HALLUCINATION 1 0.0000
236 HOT FLUSH 1 0.0000
237 INJECTION SITE SWELLING 1 0.0000
238 PRURITUS 5 0.0000
239 ABDOMINAL PAIN 3 0.0000
240 VOMITING 6 0.0000
241 PARAESTHESIA 2 0.0000
242 INJECTION SITE BRUISING 1 0.0000
243 TREATMENT FAILURE 1 0.0000
244 COMPLETED SUICIDE 1 0.0000
245 SKIN EXFOLIATION 1 0.0000
246 CEREBROVASCULAR ACCIDENT 2 0.0000
247 MYALGIA 2 0.0000
248 BALANCE DISORDER 1 0.0000
249 PYREXIA 4 0.0000
250 MUSCULOSKELETAL STIFFNESS 1 0.0000
251 DRUG INEFFECTIVE 15 0.0000
252 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
253 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
254 NASOPHARYNGITIS 2 0.0000
255 PRODUCT USE ISSUE 2 0.0000
256 NEUROPATHY PERIPHERAL 1 0.0000
257 ANAEMIA 2 0.0000
258 GAIT DISTURBANCE 2 0.0000
259 SOMNOLENCE 2 0.0000
260 CONDITION AGGRAVATED 3 0.0000
261 INJECTION SITE PAIN 3 0.0000
262 ABDOMINAL PAIN UPPER 2 0.0000
263 ARTHRALGIA 4 0.0000
264 HYPERTENSION 2 0.0000
265 PLATELET COUNT DECREASED 1 0.0000
266 FEELING ABNORMAL 2 0.0000
267 EMOTIONAL DISTRESS 1 0.0000
268 LOSS OF CONSCIOUSNESS 1 0.0000
269 HYPERHIDROSIS 1 0.0000
270 PSORIASIS 1 0.0000
271 DRY SKIN 1 0.0000
272 INFECTION 1 0.0000
273 PAIN 4 0.0000
274 HOSPITALISATION 1 0.0000
275 DRUG INTERACTION 1 0.0000
276 PNEUMONIA 2 0.0000
277 FALL 2 0.0000
278 TOXICITY TO VARIOUS AGENTS 1 0.0000
279 ASTHENIA 2 0.0000
280 ERYTHEMA 1 0.0000
281 OVERDOSE 1 0.0000
282 DECREASED APPETITE 1 0.0000
283 FATIGUE 2 0.0000
284 DIARRHOEA 1 0.0000